We are live on ! Find out more
RDUS

Radius Health, Inc.

Delisted

RDUS was delisted on the 12th of August, 2022.

1 hedge funds and large institutions have $3.16M invested in Radius Health, Inc. in 2022 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 123 closing their positions.

New
Increased
Maintained
Reduced
Closed

99% less funds holding

Funds holding: 1231 (-122)

99% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 123

99% less capital invested

Capital invested by funds: $490M → $3.16M (-$487M)

100% less funds holding in top 10

Funds holding in top 10: 30 (-3)

Holders
1
Holders Change
-122
Holders Change %
-99.19%
% of All Funds
0.02%
Holding in Top 10
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-100%
% of All Funds
New
1
Increased
Reduced
Closed
123
Calls
Puts
Net Calls
Net Calls Change

RDUS Hedge Fund Activity: Q3 2022 in Review

1 of the 5,828 institutional investors tracked by Wall St. Rank reported a position in Radius Health, Inc. (RDUS) for Q3 2022, worth a combined $3.16M — down 99% from $490M a quarter earlier.

Sellers outnumbered buyers: 123 funds closed out of RDUS and 1 opened new positions — a net loss of 122 holders — while 0 trimmed existing stakes and 0 added.

The largest buyer was Rock Creek Group, opening a new position worth an estimated $3.4M. The largest seller was Bellevue Group, exiting entirely with an estimated $91.2M sold.

  • 1 institutional investor held Radius Health, Inc. (RDUS) as of Q3 2022, down from 123 in Q2 2022.
  • Funds reported $3.16M of Radius Health, Inc. stock for Q3 2022, down 99% quarter-over-quarter.
  • 1 fund opened new Radius Health, Inc. positions in Q3 2022 and 123 closed out, a net change of -122 holders.
  • The largest Radius Health, Inc. buyer in Q3 2022 was Rock Creek Group, an estimated $3.4M added.
  • The largest Radius Health, Inc. seller in Q3 2022 was Bellevue Group, an estimated $91.2M sold.

Based on aggregated 13F filings for Q3 2022.